Ken Griffin Prime Medicine, Inc. Call Options Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$4.3 - $8.03 $70,090 - $130,888
16,300 Added 28.25%
74,000 $380,000
Q1 2024

May 15, 2024
BUY
$6.35 - $9.39 $99,695 - $147,423
15,700 Added 37.38%
57,700 $403,000
Q4 2023

Feb 14, 2024
BUY
$5.59 - $9.55 $177,762 - $303,690
31,800 Added 311.76%
42,000 $372,000
Q3 2023

Nov 14, 2023
BUY
$9.5 - $15.07 $96,900 - $153,714
10,200 New
10,200 $97,000

Others Institutions Holding PRME

# of Institutions
121
Shares Held
64.2M
Call Options Held
127K
Put Options Held
51.3K
View Full List

About Prime Medicine, Inc.

PRME Quotes by TradingView
  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $392M
More about PRME
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email